News & Events
Check out the latest from MobileODT’s media highlights, events, and accomplishments with our medical technologies.
Upcoming Events
Past Events
MobileODT Recognized for Imaging Technology Innovation in 2022 MedTech Breakthrough Awards Program
MobileODT Recognized for Imaging Technology Innovation in 2022 MedTech Breakthrough Awards Program Prestigious Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies TEL AVIV, Israel – May 9, 2022 – MobileODT, a leading...
MobileODT at Medica 2021
Artificial Intelligence for Cervical Cancer Screening - Special Daily Lecture. Come visit our booth at the Israeli Pavilion, #16J24. Join us for a daily lecture discussing the use of Artificial Intelligence in cervical cancer screening. Presented by Shahar Libay, Head...
MobileODT Selected as UCSF 2021 Health Awards Finalist
MobileODT is proud to announce that we are Finalist in the Hospital Diagnostics category for a UCSF 2021 Health Award. The UCSF Health Awards honor outstanding health technologies and innovations dramatically transforming healthcare. MobileODT was selected out of...
Israeli FemTech Company MobileODT, Engaged in Large Scale Government Cervical Cancer Screening Project.
MobileODT, an Israeli Digital Health FemTech company that is producing the latest innovation in cervical cancer screening, is proud to announce that their Visual Check AI technology is supporting a large-scale government cervical cancer screening project in the...
FemTech Company MobileODT awarded prestigious National Cancer Institute (NCI) SBIR grant of $2.3 million
January 20, 2021- Tel Aviv, Israel MobileODT, a FemTech company producing the latest digital innovation in cervical screening, has been awarded a prestigious Small Business Innovation Research Authority grant of $2.3 million. This grant is presented by the United...
MobileODT completed $4 million series round C
The round will support the development of AI cervical cancer screening device MobileODT, the developer of the EVA System for cervical cancer screening, announced the completion of a $4 million series C fundraising round. The round will enable MobileODT to further...
MobileODT completes second institutional financing
MobileODT is pleased to announce it has successfully completed its second round of institutional financing. The announcement comes shortly before the launch of its AI-based cervical cancer screening test, VisualPap. OrbiMed Israel Advisors led the round, with Tara...
MobileODT Receives Innovative Technology Contract from Vizient for the EVA System
New York, NY - August 27, 2019 - MobileODT announces its EVA (Enhanced Visual Assessment) System has received an Innovative Technology contract from Vizient, Inc. - the largest member-driven health care performance improvement company in the country. The contract was...
Beyond the pap smear: What women need to know about preventing cervical cancer
THE NEWS MINUTE (July 29, 2019) When Dr Malika Samuel embarked on a long-term study across six centres of Apollo Hospitals in Chennai, to research the incidence of cervical cancer among women in the region, she came upon an interesting finding: Doctors were able to...
Women’s Health Advocate Cherissa Jackson Joins MobileODT as Expert Advisor
June 25, 2019 TEL AVIV, Israel--MobileODT announced today that Cherissa Jackson will join its team as an expert advisor. A longtime champion in the fight against cervical cancer, Cherissa Jackson is a passionate author and motivational speaker, retired Air Force...
MobileODT is awarded the 2019 FT/IFC Transformational Business Award in Health, Wellness and Disease Prevention
MobileODT was honored to accept the 2019 FT/IFC Transformational Business Award in Health Wellness and Disease Prevention. The award ceremony was hosted in London by The Financial Times and the International Finance Corporation who have collaborated together since...
MobileODT launches EVA WELL for general gynecology in the USA
Tel Aviv, May 3, 2019: EVA WELL, the latest brand in MobileODT’s range of women’s health visualization solutions, was launched today at the American College of Obstetricians and Gynecologists (ACOG) annual conference in Nashville, TN. Designed for general gynecology,...
MobileODT’s CDS algorithm shows impressive results in first real-time application of AVE for cervical cancer screening
Seoul, South Korea: The first prospective pilot into artificial intelligence for point-of-care visual cervical cancer detection found it to be more effective than current laboratory-based methods. Automated visual evaluation is the next step in the journey to leverage...
MobileODT wins MEDinISRAEL Innovation Award – Affordability Track
Tel Aviv, March 3, 2019: MobileODT was awarded the Innovation Award first prize in the Affordability Track at the 2019 MEDinISRAEL conference. MobileODT’s VP Revenue, Adi Jacobson received the award in recognition of the company’s work in developing the AVE (automated...
6 innovations from Future Healthcare 2019
MEDICAL NEWS TODAY (March 22, 2019) During the 2019 Future Healthcare event in London, MobileODT was honored to present the EVA System during the Health Innovations Theatre. From over 350 brands that attended, MobileODT was featured in Medical News Today as one of the...